Navigation Links
Researchers report the cloning of a key group of human genes, the protein kinases
Date:5/2/2008

Although the human genome has been sequenced, research into mechanism of action of genes has been hampered by the fact that most human genes have not been isolated. This is true for even the most common class of cancer-associated genes, the protein kinases, which mediate the majority of signaling events in cells by phosphorylating and modulating the activity of other proteins. It has been estimated by systematic gene sequencing efforts that up to a quarter of kinases may play a role in human cancers.

In a study published in the 2nd of May issue of Cell, a research teams led by Professor Jussi Taipale from the National Public Health Institute and University of Helsinki, Finland, Professor Olli Kallioniemi from Institute for Molecular Medicine Finland (FIMM), and Dr. Wei-Wu He from the US-based biotechnology company Origene Technologies, Inc., report cloning of nearly all predicted human protein kinase genes in functional form, and generation of a corresponding set of kinases lacking catalytic activity that are necessary for functional studies. They further used the kinome collection in several high-throughput screens, including a screen which identified two novel kinases regulating the Hedgehog signaling pathway a key pathway linked to multiple types of human cancer. In addition, together with the group of Dr. Pivi Ojala, University of Helsinki, they identified a novel kinase required for activation of Kaposis sarcoma herpesvirus.

The isolated kinase genes form a resource that scientist can now use to systematically map kinase signaling networks in different cellular disease models. The kinases are also promising targets for therapeutic intervention in the treatment of various cancers, Professor Taipale states.


'/>"/>

Contact: Jussi Taipale
jussi.taipale@helsinki.fi
358-919-125-556
University of Helsinki
Source:Eurekalert

Page: 1

Related biology news :

1. Researchers identify proteins involved in new neurodegenerative syndrome
2. Texas researchers and educators head for Antarctica
3. MGH researchers describe new way to identify, evolve novel enzymes
4. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
5. U of MN researchers discover noninvasive diagnostic tool for brain diseases
6. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
7. Researchers discover new strategies for antibiotic resistance
8. Researchers find new taste in fruit flies: carbonated water
9. Binghamton University researchers investigate evolving malaria resistance
10. UIC researchers find promising new targets for antibiotics
11. Researchers develop simple method to create natural drug products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2018)... ... 2018 , ... The first ever production picosecond-domain laser with a 785?nm wavelength ... tattoo inks - often the colors most resistant to laser removal. , A clinical ... American Society for Laser Medicine and Surgery, Inc. (ASLMS) investigated the safety and efficacy ...
(Date:9/12/2018)... PARK, Calif. (PRWEB) , ... September 10, 2018 ... ... that a paper detailing the performance of its new Multiplexed Ion Beam Imaging ... the September 6 issue. This study will also be shared during a webinar ...
(Date:9/12/2018)... ... September 12, 2018 , ... JoVE, the ... pleased to support the professional development of academic librarians by sponsoring four award-winners ... entrants were asked to submit successful strategies to increase collaboration among librarians and ...
Breaking Biology News(10 mins):
(Date:9/12/2018)... Calif. and VIENNA, Austria (PRWEB) , ... September 10, 2018 , ... ... leading supplier of Semantic Graph Database technology, AllegroGraph , for Knowledge Graphs, and ... leading provider of Semantic AI solutions, today announced a partnership to develop the ...
(Date:9/7/2018)... Calif. (PRWEB) , ... September 05, 2018 , ... Now ... Park Systems will be held on Sept. 19, 2018. With a panel of industry ... SPM, this exciting event will reveal industry insights from experts in the field. ...
(Date:9/7/2018)... ... September 06, 2018 , ... Akadeum Life Sciences today announced it ... as an executive and leader of numerous biotech companies. , He most recently ... company acquired by Thompson Street Capital in St. Louis, MO. Prior to ISTO, ...
(Date:8/29/2018)... ... August 28, 2018 , ... ... announced today the successful completion of a $5.5 million funding round managed by ... Investment Fund, Commenda Capital, and Ellipsis Ventures. , “Our investment in Nanovis is ...
Breaking Biology Technology: